About Aurion Biotech
Aurion Biotech is a clinical stage biotech company, developing a transformational platform of advanced therapies to cure blindness.
Leadership at Aurion Biotech
The team at the top of the org chart.
Judith Mcgarry
VP, Marketing & Communications
Arnaud Lacoste, PhD MBA
Chief Executive Officer
50 reports
Hiromi Urasawa
安全管理部 部長 Director Of Safety Management,事業本部 部長 Director Of Business Development
Sterling Chung
Vice President, Regulatory Affairs And Quality
Xin Qu
Senior Director, BioEngineering and Therapeutics Delivery
Pranay Khare
Sr. Director
1 report
Christy Faull
Controller
Gwen Anderson
Director, Real Estate and Facilities
Saba Kadlec
Executive Director Of Clinical Development
3 reports
Katherine McMurry
Clinical Trial Manager
Brad Andrew Shutzberg
Vice President, Finance
2 reports
Arnaud Lacoste
CSO
Lan le
Executive Director
40 reports
Kazuya Inoue
事業本部長
Andrew Torres
Chief Manufacturing Officer
2 reports
Eris Jordan
VP, Global Clinical & Medical Affairs
Matt Fowler
Interim Chief Financial Officer
J.d. Osborne
Vice President Of Alliance Management
Sara Rosetti
Vice President, Human Resources
Board
Shigeru Kinoshita
Advisor
Edward Holland
Advisory Board Chair
John Berdahl
Advisor
Eric Donnenfeld
Advisor
Nicole Fram
Advisor
Terry Kim
Advisor